Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Encompass Health Corp
Bear Case (25th pct.)
-36.9% vs price
Base Case (Median)
-16.5% vs price
Bull Case (75th pct.)
11.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $100.00 | -16.5% | High (40%) |
| PE Comparable | $137.87 | 15.1% | Medium (25%) |
| Growth Trajectory DCF | $222.11 | 85.4% | Medium (20%) |
| Graham Number | $58.39 | -51.3% | Medium (40%) |
| EV/EBITDA | $92.77 | -22.6% | Medium (20%) |
| EV/FCF | $53.96 | -55.0% | Medium (20%) |
| Earnings Power Value | $130.28 | 8.7% | Medium (50%) |
Based on 7 out of 7 methods, EHC appears fairly valued at the current price of $119.80. The base case fair value of $100.00 implies 16.5% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.